<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03941899</url>
  </required_header>
  <id_info>
    <org_study_id>0081052</org_study_id>
    <nct_id>NCT03941899</nct_id>
  </id_info>
  <brief_title>The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)</brief_title>
  <acronym>QLBII</acronym>
  <official_title>The Analgesic Effect of Qudratus Lomborum Block II Type After Robotic-Assisted Laparoscopic Radical Prostatectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Salvatore Hospital of L'Aquila</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Salvatore Hospital of L'Aquila</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The analgesic effects of Quadratus Lomborum Block II type after robotic-assisted laparoscopic&#xD;
      radical prostatectomy, will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Quadratus Lomborum Block II type will be performed before performing robotic-assisted&#xD;
      laparoscopic radical prostatectomy.&#xD;
&#xD;
      The post-operative analgesic effect will be assessed, by using Numeric Rate Scale for pain.&#xD;
&#xD;
      The pain assessment will be evaluated during the first 24 hours from surgery. The opioids&#xD;
      requirement and side effects will be also assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 6, 2019</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">December 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Simon's Two-Stage single arm study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analgesia</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>Pain assessment by using Numeric Rate Scale for pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioids</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>The opioids requirement (mg of equianalgesic morphine) will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Nausea and Vomiting</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>The postoperative nausea and vomiting will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel function</measure>
    <time_frame>The first 24 hours from surgery</time_frame>
    <description>The recovery of bowel function will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Day after surgery</time_frame>
    <description>The length of stay after surgery will be assessed</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>QLB II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Quadratus Lomborum Blocck II type will be performed before robot-assisted laparoscopic radical prostatectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Levobupivacaine in QLB II</intervention_name>
    <description>Quadratus Lomborum Block II type will be performed by injecting levobupivacaine 0.375% 20 ml between latissimus dorsi and quadratus lomborum muscle.</description>
    <arm_group_label>QLB II</arm_group_label>
    <other_name>Quadratus Lomborum Block II type</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologist status I-III&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body mass Index &gt; 35 kg/m2&#xD;
&#xD;
          -  Allergies to local anesthetics&#xD;
&#xD;
          -  primaries or secondaries coagulopathies&#xD;
&#xD;
          -  addiction to drugs&#xD;
&#xD;
          -  severe kidney and liver diseases&#xD;
&#xD;
          -  cognitive impairment&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients undergoing to robotic-assisted laparoscopic radical prostatectomy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franco Marinangeli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>San Salvatore Academic Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Salvatore Academic Hospital</name>
      <address>
        <city>Coppito</city>
        <state>L'Aquila</state>
        <zip>67100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>May 1, 2021</last_update_submitted>
  <last_update_submitted_qc>May 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Salvatore Hospital of L'Aquila</investigator_affiliation>
    <investigator_full_name>Emiliano Petrucci</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain, radical prostatectomy, QLB II type</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

